Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan
· Delayed Price · Currency is TWD 90.90
-2.90 (-3.09%)
Jun 27, 2025, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 12.26 billion as of June 27, 2025. Its market cap has decreased by -40.23% in one year.
Market Cap
12.26B
Enterprise Value
10.37B
Revenue
34.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
90.90
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.26B, an increase of 38.29%. That is a compound annual growth rate of 3.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 190.00B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 83.99B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 31.37B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.35B |
| Lumosa Therapeutics | 25.66B |